Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NeurogesX Reports Positive Phase 2 Results for NGX-1998 for Treatment of Postherpetic Neuralgia
Yahoo
Tuesday, November 8, 2011 - 10:35am
tags:
NGX-1998, NeurogesX, postherpetic neuralgia
Santarus' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, November 8, 2011 - 10:34am
tags:
earnings, Santarus
Insmed Inc. Earnings Cheat Sheet: Loss Widens, Falls Below Estimates
Yahoo/Wall St. Cheat Sheet
Tuesday, November 8, 2011 - 10:33am
tags:
Insmed, earnings
Vivus Posts Narrower Loss
Yahoo/Zacks.com
Tuesday, November 8, 2011 - 10:33am
tags:
earnings, Vivus
Targacept Depression Drug Fails Late-Stage Study
TheStreet.com
Tuesday, November 8, 2011 - 10:32am
tags:
depression, Targacept, AstraZeneca, TC-5214
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Motley Fool
Tuesday, November 8, 2011 - 10:31am
tags:
diabetes, Eli Lilly, exenatide, Amylin
Baxter says immune drug reduced infections
Yahoo/AP
Monday, November 7, 2011 - 9:19pm
tags:
Baxter, HyQ, immune disorders
Nabi reviewing options after smoking vaccine fails
Yahoo/AP
Monday, November 7, 2011 - 9:17pm
tags:
Nabi, smoking cessation, vaccine, NicOx
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Monday, November 7, 2011 - 9:15pm
tags:
Erbitux, Bristol-Myers Squibb, ImClone, Eli Lilly, head and neck cancer
Amgen Stock Rises on New Buyback Plan, But How About the Debt?
Barron's
Monday, November 7, 2011 - 9:13pm
tags:
Amgen, debt, stock buyback
1 Reason the Street Should Love Eli Lilly's Earnings
Motley Fool
Monday, November 7, 2011 - 9:12pm
tags:
earnings, Eli Lilly
Lipitor's $131B lifetime sales dwarf other megablockbusters
Fierce Pharma
Monday, November 7, 2011 - 12:09pm
tags:
Lipitor, Pfizer, statins, drug data, Plavix, Zocor, Seretide, Advair, Nexium
Novartis drug helps in severe childhood arthritis
Reuters
Monday, November 7, 2011 - 12:05pm
tags:
Novartis, juvenile arthritis, Ilaris, systemic juvenile idiopathic arthritis
Free Speech, Fraud And Clinical Trial Statistics
Pharmalot
Monday, November 7, 2011 - 12:02pm
tags:
clinical trials, fraud, free speech, Medicare, Medicaid, InterMune
Biotechs And Their Trials By Fire
Seeking Alpha
Monday, November 7, 2011 - 11:57am
tags:
MannKind, Keryx, Dendreon, Arena, Biocryst, Aeterna Zentaris, Advanced Cell Technologies
Amgen jumps 5% on $5 billion stock buy-back
Marketwatch
Monday, November 7, 2011 - 11:55am
tags:
Amgen, stock buyback
Cubist begins tender offer for Adolor
Bizjournals.com
Monday, November 7, 2011 - 11:55am
tags:
Cubist, Adolor, M&A
Inhibitex's Future Looks Promising
Seeking Alpha
Monday, November 7, 2011 - 11:09am
tags:
Inhibitex, INX-189, Aurexis, FV100
NPS wraps another positive PhIII study as parathyroid drug impresses
Fierce Biotech
Monday, November 7, 2011 - 11:07am
tags:
NPS Pharmaceuticals, hypoparathyroidism, NPSP558
Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate
Bloomberg
Monday, November 7, 2011 - 11:02am
tags:
Pharmasset, hepatitis C, PSI-7977

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.